Wockhardt Exits US Generics: Morton Grove Liquidation Signals Strategic Shift

Unknown Apr 02, 2026 750 Views

Wockhardt Ltd has filed for voluntary liquidation of its US subsidiaries—Morton Grove Pharmaceuticals Inc and Wockhardt USA LLC—marking a formal exit from the US generic drug segment. This follows years of regulatory setbacks and operational inefficiencies at its Illinois facility....